Nochimson Ross L DO is categorized under Physical Medicine, Physician/Surgeon in Clifton, NJ and active since 2012.
Nochimson Ross L DO was established in 2012, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Physical Medicine, Physician/Surgeon business, which does work in the B2C market, and is classified as a Physical Medicine, Physician/Surgeon, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Ross Nochimson at the company’s single location by writing to 1187 Main Avenue # 3d, Clifton, New Jersey NJ 07011 or by phoning (973) 928-6826. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Nochimson Ross L DO |
| Contact Person: | Ross Nochimson |
| Address: | 1187 Main Avenue # 3d, Clifton, New Jersey 07011 |
| Phone Number: | (973) 928-6826 |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 2012 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Physical Medicine, Physician/Surgeon |
| SIC Code: | 8011 |
| NAICS Code: | 6211110 |
| Share This Business: |
Nochimson Ross L DO was started in 2012 to provide professional Physical Medicine, Physician/Surgeon under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Ross Nochimson for inquiries that concern Nochimson Ross L DO by calling the company number (973) 928-6826, as your correspondence is most welcome. Additionally, the physical location of the single location of Nochimson Ross L DO can be found at the coordinates 40.87638,-74.14075 as well as the street address 1187 Main Avenue # 3d in Clifton, New Jersey 07011.
For its online presence, you may visit Nochimson Ross L DO’s website at and engage with its social media outlets through on Twitter and on Facebook.